Pinpointing key genetic variations in an individual, understanding the biological — and disease — consequences of those variations, and devising personalized treatments will go “from genome to bedside in three years,” says Richard Gibbs, director and founder of the Human Genome Sequencing Center at the Baylor College of Medicine.